Lunai Bioworks
LNAI
22 hedge funds and large institutions have $982K invested in Lunai Bioworks in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
10% more funds holding
Funds holding: 20 → 22 (+2)
0.53% more ownership
Funds ownership: 0.06% → 0.59% (+0.53%)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
29% less capital invested
Capital invested by funds: $1.38M → $982K (-$399K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
+$27K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$23K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$17.9K |
| 4 |
Jane Street
New York
|
+$13.3K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$12.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$53.6K |
| 2 |
Millennium Management
New York
|
-$40.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$23K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21.7K |
| 5 |
Goldman Sachs
New York
|
-$3.97K |
LNAI Hedge Fund Activity: Q4 2025 in Review
22 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Lunai Bioworks (LNAI) for Q4 2025, worth a combined $982K — down 29% from $1.38M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LNAI positions and 5 closed out — a net gain of 2 holders — while 5 added to existing stakes and 7 trimmed.
The largest buyer was Nine Masts Capital, opening a new position worth an estimated $27K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $53.6K sold.
- 22 institutional investors held Lunai Bioworks (LNAI) as of Q4 2025, up from 20 in Q3 2025.
- Funds reported $982K of Lunai Bioworks stock for Q4 2025, down 29% quarter-over-quarter.
- 7 funds opened new Lunai Bioworks positions in Q4 2025 and 5 closed out, a net change of +2 holders.
- The largest Lunai Bioworks buyer in Q4 2025 was Nine Masts Capital, an estimated $27K added.
- The largest Lunai Bioworks seller in Q4 2025 was Renaissance Technologies, an estimated $53.6K sold.
Based on aggregated 13F filings for Q4 2025.